MPM BioImpact’s Veru VERU Stock Holding History

MPM BioImpact’s Portfolio VERU Stock Details VERU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-491,195	Closed	-$2.86M	–	50
2025 Q2	$2.86M	Sell	491,195 -168,078	-25%	-$944K	0.5%	39
2025 Q1	$3.23M	Buy	659,273 +230,736	+54%	+$1.43M	0.56%	38
2024 Q4	$2.79M	Buy	+428,537	New	+$3.18M	0.4%	44

Other funds holding VERU

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SSIM

Sheets Smith Investment Management Houston, Texas $154M AUM 66.97% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PAM

PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MPM BioImpact's VERU Position: Q3 2025 in Review

MPM BioImpact sold out of Veru (VERU) in Q3 2025, closing a stake of 491,195 shares — an estimated $2.86M sold.

MPM BioImpact first reported a position in VERU in Q4 2024 and held it in 3 quarters. The position peaked at $3.23M in Q1 2025. 65 funds tracked by Wall St. Rank hold VERU as of Q3 2025.

MPM BioImpact reported no remaining Veru position as of Q3 2025 after selling out during the quarter.
MPM BioImpact sold 491,195 Veru shares in Q3 2025, an estimated $2.86M.
MPM BioImpact first reported a position in Veru in Q4 2024 and held it in 3 quarters.
MPM BioImpact's Veru position peaked at $3.23M in Q1 2025.
65 funds tracked by Wall St. Rank held Veru as of Q3 2025.

Based on MPM BioImpact's 13F filing for Q3 2025, filed 14 Nov 2025.